The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nimotuzumab combined with chemotherapy plus immunotherapy as first-line treatment for advanced esophageal squamous cell carcinoma.
 
Quanli Han
No Relationships to Disclose
 
Qi Wang
No Relationships to Disclose
 
Zhi Cui
No Relationships to Disclose
 
Muhong Deng
No Relationships to Disclose
 
Yue Ma
No Relationships to Disclose
 
Fang Pang
No Relationships to Disclose